[1]林志坤,邹小君,王文浩,等.血管造影阴性的蛛网膜下腔出血病人预后的相关因素[J].中国临床神经外科杂志,2023,28(04):275-276.[doi:10.13798/j.issn.1009-153X.2023.04.016]
点击复制

血管造影阴性的蛛网膜下腔出血病人预后的相关因素()
分享到:

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
28
期数:
2023年04期
页码:
275-276
栏目:
经验介绍
出版日期:
2023-04-30

文章信息/Info

文章编号:
1009-153X(2023)04-0275-02
作者:
林志坤邹小君王文浩林俊明黄巍张明升
363000福建漳州,联勤保障部队第九〇九医院(厦门大学附属东南医院)神经外科(林志坤、邹小君、王文浩、林俊明、黄巍、张明升)
关键词:
血管造影阴性的蛛网膜下腔出血预后影响因素
分类号:
B
DOI:
10.13798/j.issn.1009-153X.2023.04.016
文献标志码:
R743.9
摘要:
目的 探讨血管造影阴性蛛网膜下腔出血(SAH)病人预后的影响因素。方法 回顾性分析2019年10月至2021年10月经3D-DSA确诊的50例血管造影阴性SAH的临床资料。出血90 d,采用改良Rankin评分(mRS)评估预后,其中1~2分为预后良好,3~6分为预后不良。结果 50例中,预后不良10例,预后良好40例。单因素分析发现,高血压病、糖尿病、饮酒史、Hunt-Hess分级分级、WFNS分级与病人预后相关(P<0.05)。多因素logistic回归分析发现,高血压病是病人预后不良的独立危险因素(OR=11.826;95% CI 1.240~112.801;P=0.032)。结论 多数血管造影阴性SAH病人的预后良好;合并高血压病的病人,预后不良风险增加,应密切随访。

参考文献/References:

[1]Caceres JA, Goldstein JN. Intracranial hemorrhage [J]. Emerg Med Clin North Am, 2012, 30(3): 771-794.
[2]Boswell S, Thorell W, Gogela S, et al. Angiogram-negative subarachnoid hemorrhage: outcomes data and review of the literature [J]. J Stroke Cerebrovasc Dis, 2013, 22: 750-757.
[3]Kumar R, Das KK, Sahu RK, et al. Angionegative spontaneous subarachnoid hemorrhage: is repeat angiogram required in all cases [J]. Surg Neurol Int, 2014, 5(8): 125.
[4]Mensing LA, Vergouwen MDI, Laban KG, et al. Perimesen-cephalic hemorrhage: a review of epidemiology, risk factors, presumed cause, clinical course, and outcome [J]. Stroke, 2018, 49(6): 1363-1370.
[5]Ois A, Vivas E, Figueras-Aguirre G, et al. Misdiagnosis worsens prognosis in subarachnoid hemorrhage with good hunt and hess score [J]. Stroke, 2019, 50(11): 3072-3076.
[6]Bacigaluppi S, Bragazzi NL, Ivaldi F, et al. Systemic inflam-matory response in spontaneous subarachnoid hemorrhage from aneurysmal rupture versus subarachnoid hemorrhage of unknown origin [J]. J Inflamm Res, 2022, 15(11): 6329-6342.
[7]Konczalla J, Kashefiolasl S, Brawanski N, et al. Increasing numbers of nonaneurysmal subarachnoid hemorrhage in the last 15 years: antithrombotic medication as reason and prognostic factor [J]. J Neurosurg, 2016, 124(6): 1731-1737.
[8]Kumar N, Gupta S. Factors determining outcome of post-angiogram-negative subarachnoid hemorrhage [J]. J Post-grad Med, 2021, 67(4): 213-218.
[9]Naidech AM, Janjua N, Kreiter KT, et al. Predictors and impact of aneurysm rebleeding after subarachnoid hemo-rrhage [J]. Arch Neurol, 2005, 62(3): 410-416.
[10]Gupta SK, Gupta R, Khosla VK, et al. Nonaneurysmal nonperimesencephalic subarachnoid hemorrhage: is it a benign entity [J]. Surg Neurol, 2009, 71(5): 566-571.
[11]Korja M, Thorn LM, Hogg S, et al. Subarachnoid hemo-rrhage in type 1 diabetes: a prospective cohort study of 4, 083 patients with diabetes [J]. Diabetes Care, 2013, 36(11): 3754-3758.
[12]Guarino F, Cantarella G, Caruso M, et al. Endothelial activation and injury by cigarette smoke exposure [J]. J Biol Regul Homeost Agents, 2011, 25(2): 259-268.

相似文献/References:

[1]于 涛 黄正通 王振宇.椎管内脊膜囊肿的临床特征和治疗方法[J].中国临床神经外科杂志,2015,(11):654.[doi:10.13798/j.issn.1009-153X.2015.11.005]
 YU Tao,HUANG Zheng-tong,WANG Zhen-yu.Clinical features and treatment of intraspinal arachnoid cysts[J].,2015,(04):654.[doi:10.13798/j.issn.1009-153X.2015.11.005]
[2]李剑峰 陈银生 赛 克 张湘衡 柯 超 杨群英 牟永告 许海雄 陈忠平.173例胶质瘤预后的影响因素分析[J].中国临床神经外科杂志,2016,(06):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
 LI Jian-feng,CHEN Yin-sheng,SAI Ke,et al.Prognostic factors for gliomas: analysis of 173 cases[J].,2016,(04):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
[3]谢宝树 张 林 王 宇 贾 锋 殷玉华.复发性多发胶质母细胞瘤的预后分析[J].中国临床神经外科杂志,2016,(06):333.[doi:10.13798/j.issn.1009-153X.2016.06.005]
 XIE Bao-shu,ZHANG Lin,WANG Yu,et al.Analysis of prognoses in patients with recurrent multiple glioblastomas[J].,2016,(04):333.[doi:10.13798/j.issn.1009-153X.2016.06.005]
[4]周 量 刘 丛 张昌伟.早期栓塞术治疗动脉瘤性蛛网膜下腔出血的疗效[J].中国临床神经外科杂志,2016,(07):410.[doi:10.13798/j.issn.1009-153X.2016.07.007]
 ZHOU Liang,LIU Cong,ZHANG Chang-wei..Curative effect of early endovascular embolization on patients with ruptured intracranial aneurysms[J].,2016,(04):410.[doi:10.13798/j.issn.1009-153X.2016.07.007]
[5]陈吉钢 张丹枫 魏嘉良 邹 伟 侯立军.创伤性眶上裂综合征的治疗陈吉钢[J].中国临床神经外科杂志,2016,(04):200.[doi:10.13798/j.issn.1009-153X.2016.04.003]
 CHEN Ji-gang,ZHANG Dan-feng,WEI Jiang-liang,et al.Management of traumatic superior orbital fissure syndrome (report of 22 cases)[J].,2016,(04):200.[doi:10.13798/j.issn.1009-153X.2016.04.003]
[6]申彦杰 宋 健 成文平 程东亮.微血管减压术治疗面肌痉挛57例[J].中国临床神经外科杂志,2016,(04):238.[doi:10.13798/j.issn.1009-153X.2016.04.016]
[7]朱作磊 综述 罗良生 审校.动脉瘤性蛛网膜下腔出血的预后相关因素研究进展[J].中国临床神经外科杂志,2016,(03):183.[doi:10.13798/j.issn.1009-153X.2016.03.020]
[8]李玉龙 方兴根 李真保 吴德刚 赖年升 赵心同 徐善水 狄广福.血管内治疗颈内动脉床突旁破裂动脉瘤[J].中国临床神经外科杂志,2016,(02):79.[doi:10.13798/j.issn.1009-153X.2016.02.006]
 LI Yu-long,FANG Xing-gen,LI Zhen-bao,et al.Endovascular embolization of ruptured paraclinoid aneurysms (report of 26 cases)[J].,2016,(04):79.[doi:10.13798/j.issn.1009-153X.2016.02.006]
[9]皮水平 刘 杰 黄前樟.长期服用抗凝药物的老年颅脑损伤患者治疗体会[J].中国临床神经外科杂志,2016,(02):117.[doi:10.13798/j.issn.1009-153X.2016.02.022]
[10]淦 超 李朝曦 刘胜文 陈 娟 王宝峰 徐 钰 张华楸 雷 霆.垂体Rathke's囊肿性质与患者临床表现和预后的相关性分析[J].中国临床神经外科杂志,2015,(10):580.[doi:10.13798/j.issn.1009-153X.2015.10.002]
 GAN Chao,LI Chao-xi,LIU Sheng-wen,et al.Analysis of relationship of pituitary Rathke's cleft cyst texture with clinical symptoms and prognosis[J].,2015,(04):580.[doi:10.13798/j.issn.1009-153X.2015.10.002]

备注/Memo

备注/Memo:
(2022-11-15收稿,2023-02-10修回)
通讯作者:王文浩,E-mail:wwh196407@163.com
更新日期/Last Update: 2022-04-30